News
DMTTF
0.133
+10.42%
0.013
Weekly Report: what happened at DMTTF last week (0226-0301)?
Weekly Report · 03/04 09:59
Weekly Report: what happened at DMTTF last week (0219-0223)?
Weekly Report · 02/26 10:05
Weekly Report: what happened at DMTTF last week (0212-0216)?
Weekly Report · 02/19 10:06
Weekly Report: what happened at DMTTF last week (0205-0209)?
Weekly Report · 02/12 10:00
Weekly Report: what happened at DMTTF last week (0129-0202)?
Weekly Report · 02/05 10:05
Weekly Report: what happened at DMTTF last week (0122-0126)?
Weekly Report · 01/29 10:00
Weekly Report: what happened at DMTTF last week (0115-0119)?
Weekly Report · 01/22 10:02
Weekly Report: what happened at DMTTF last week (0108-0112)?
Weekly Report · 01/15 10:00
Weekly Report: what happened at DMTTF last week (0101-0105)?
Weekly Report · 01/08 10:02
Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD
MAPS Public Benefit Corporation has raised over $100 million in a Series A private stock sale. The funds will support the organization's application for approval to sell MDMA as a treatment for post-traumatic stress disorder. The organization will change its name to Lykos Therapeutics.
Benzinga · 01/06 20:59
Weekly Report: what happened at DMTTF last week (1225-1229)?
Weekly Report · 01/01 09:59
Weekly Report: what happened at DMTTF last week (1218-1222)?
Weekly Report · 12/25/2023 10:05
Weekly Report: what happened at DMTTF last week (1211-1215)?
Weekly Report · 12/18/2023 10:07
Weekly Report: what happened at DMTTF last week (1204-1208)?
Weekly Report · 12/11/2023 10:05
Weekly Report: what happened at DMTTF last week (1127-1201)?
Weekly Report · 12/04/2023 10:05
Weekly Report: what happened at DMTTF last week (1120-1124)?
Weekly Report · 11/27/2023 10:01
Weekly Report: what happened at DMTTF last week (1113-1117)?
Weekly Report · 11/20/2023 10:01
Weekly Report: what happened at DMTTF last week (1106-1110)?
Weekly Report · 11/13/2023 09:58
Weekly Report: what happened at DMTTF last week (1030-1103)?
Weekly Report · 11/06/2023 10:00
Weekly Report: what happened at DMTTF last week (1023-1027)?
Weekly Report · 10/30/2023 10:07
More
Webull provides a variety of real-time DMTTF stock news. You can receive the latest news about Small Pharma through multiple platforms. This information may help you make smarter investment decisions.
About DMTTF
Small Pharma Inc., formerly Unilock Capital Corp, is a Canada-based neuropharmaceutical company. The Company is specialized in development of treatments for mental health conditions, with a focus on depression. Small Pharma is focused on developing N,N-dimethyltryptamine (DMT) and a pipeline of patent-protected deuterium-enriched tryptamine compounds in combination with psychotherapy as potential rapid onset, sustained treatments for depression and other mental health disorders. The Company is progressing the development of DMT-assisted therapy, using its synthetic formulation, SPL026, alongside psychotherapy. Its pipeline also includes SPL028, SPL029 and SPL801B.